Trials / Sponsors / Translational Genomics Research Institute
Translational Genomics Research Institute
Academic / Other · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | A SU2C Catalyst® Trial of a PD1 Inhibitor With or Without a Vitamin D Analog for the Maintenance of Pancreatic Pancreatic Cancer, Pancreas Adenocarcinoma, Advanced Pancreatic Cancer | Phase 2 | 2017-12-27 |
| Completed | Studies in Patients With Tuberous Sclerosis Complex Tuberous Sclerosis Complex | — | 2016-05-01 |
| Withdrawn | Study of Capecitabine and Cetuximab as First-Line Therapy in Patients With Metastatic Wild Type Kirsten Rat Sa Metastatic Colorectal Cancer | Phase 2 | 2009-08-01 |